{"title":"基于热力学saft状态方程的小分子药物溶解度参数预测。","authors":"Hashem O Alsaab, Saeed Shirazian","doi":"10.1016/j.ejps.2025.107338","DOIUrl":null,"url":null,"abstract":"<p><p>Accurate prediction of drug solubility parameters plays a crucial role in optimizing pharmaceutical formulations. In this study, the solubility parameters of pharmaceutical compounds are estimated using the Perturbed Chain Statistical Associating Fluid Theory (PC-SAFT) equation of state (EoS). It should be noted that experimental values of drug solubility parameters are scarce, and group contribution (GC) methods have several significant limitations. Solubility is influenced by factors such as steric hindrance and intramolecular hydrogen bonding, which are not captured by GC approaches. As well, most GC tables are based on common organic functional groups, whereas many drugs contain rare or novel groups, making GC-based estimates either unavailable or unreliable. It is the first attempt to predict the solubility parameter of pharmaceuticals using a SAFT-based EoS. The PC-SAFT EoS parameters were calculated from binary experimental solubility data and subsequently applied to predict drug solubility parameters. To enhance model performance, the association interactions between drug-drug and drug-solvent molecules were explicitly considered. The effect of each contribution (hard-chain, dispersion, and hydrogen bonding) on solubility parameter prediction has been investigated. The results demonstrate that hydrogen-bonding interaction plays a critical role in accurately predicting solubility parameters. In addition to using the PC-SAFT EoS, an unconstrained regression approach (URA) was employed as a complementary method. In the URA, experimental solubility data were incorporated to establish correlations for the Hansen solubility terms. The predictions obtained with PC-SAFT EoS were compared to those from regression model and GC approaches, showing that the PC-SAFT approach provides satisfactory accuracy for drug solubility parameter estimation. This approach provides a tool for pre-designing new drug candidates by optimizing solvent selection in chemical processes.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107338"},"PeriodicalIF":4.7000,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prediction of Small-molecule Pharmaceuticals Solubility Parameters Using a Thermodynamic SAFT-based Equation of State.\",\"authors\":\"Hashem O Alsaab, Saeed Shirazian\",\"doi\":\"10.1016/j.ejps.2025.107338\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Accurate prediction of drug solubility parameters plays a crucial role in optimizing pharmaceutical formulations. In this study, the solubility parameters of pharmaceutical compounds are estimated using the Perturbed Chain Statistical Associating Fluid Theory (PC-SAFT) equation of state (EoS). It should be noted that experimental values of drug solubility parameters are scarce, and group contribution (GC) methods have several significant limitations. Solubility is influenced by factors such as steric hindrance and intramolecular hydrogen bonding, which are not captured by GC approaches. As well, most GC tables are based on common organic functional groups, whereas many drugs contain rare or novel groups, making GC-based estimates either unavailable or unreliable. It is the first attempt to predict the solubility parameter of pharmaceuticals using a SAFT-based EoS. The PC-SAFT EoS parameters were calculated from binary experimental solubility data and subsequently applied to predict drug solubility parameters. To enhance model performance, the association interactions between drug-drug and drug-solvent molecules were explicitly considered. The effect of each contribution (hard-chain, dispersion, and hydrogen bonding) on solubility parameter prediction has been investigated. The results demonstrate that hydrogen-bonding interaction plays a critical role in accurately predicting solubility parameters. In addition to using the PC-SAFT EoS, an unconstrained regression approach (URA) was employed as a complementary method. In the URA, experimental solubility data were incorporated to establish correlations for the Hansen solubility terms. The predictions obtained with PC-SAFT EoS were compared to those from regression model and GC approaches, showing that the PC-SAFT approach provides satisfactory accuracy for drug solubility parameter estimation. This approach provides a tool for pre-designing new drug candidates by optimizing solvent selection in chemical processes.</p>\",\"PeriodicalId\":12018,\"journal\":{\"name\":\"European Journal of Pharmaceutical Sciences\",\"volume\":\" \",\"pages\":\"107338\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-10-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutical Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejps.2025.107338\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejps.2025.107338","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Prediction of Small-molecule Pharmaceuticals Solubility Parameters Using a Thermodynamic SAFT-based Equation of State.
Accurate prediction of drug solubility parameters plays a crucial role in optimizing pharmaceutical formulations. In this study, the solubility parameters of pharmaceutical compounds are estimated using the Perturbed Chain Statistical Associating Fluid Theory (PC-SAFT) equation of state (EoS). It should be noted that experimental values of drug solubility parameters are scarce, and group contribution (GC) methods have several significant limitations. Solubility is influenced by factors such as steric hindrance and intramolecular hydrogen bonding, which are not captured by GC approaches. As well, most GC tables are based on common organic functional groups, whereas many drugs contain rare or novel groups, making GC-based estimates either unavailable or unreliable. It is the first attempt to predict the solubility parameter of pharmaceuticals using a SAFT-based EoS. The PC-SAFT EoS parameters were calculated from binary experimental solubility data and subsequently applied to predict drug solubility parameters. To enhance model performance, the association interactions between drug-drug and drug-solvent molecules were explicitly considered. The effect of each contribution (hard-chain, dispersion, and hydrogen bonding) on solubility parameter prediction has been investigated. The results demonstrate that hydrogen-bonding interaction plays a critical role in accurately predicting solubility parameters. In addition to using the PC-SAFT EoS, an unconstrained regression approach (URA) was employed as a complementary method. In the URA, experimental solubility data were incorporated to establish correlations for the Hansen solubility terms. The predictions obtained with PC-SAFT EoS were compared to those from regression model and GC approaches, showing that the PC-SAFT approach provides satisfactory accuracy for drug solubility parameter estimation. This approach provides a tool for pre-designing new drug candidates by optimizing solvent selection in chemical processes.
期刊介绍:
The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development.
More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making.
Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.